Revvity
About The Revvity
Industry
Other
Revvity, Inc., formerly known as PerkinElmer, Inc., is a leading American company specializing in health science solutions, technologies, and services. Established in 1937 and headquartered in Waltham, Massachusetts, Revvity focuses on delivering comprehensive workflows from discovery to development and diagnosis to cure.
In 2022, PerkinElmer underwent a strategic transformation, selling its applied, food, and enterprise services businesses for $2.45 billion. This move allowed the company to concentrate exclusively on life sciences and diagnostics, culminating in the rebranding to Revvity, Inc. in April 2023.
Products and Services
Revvity's offerings encompass a wide range of products and services, including reagents, consumables, assays, instruments, and software. These solutions cater to diverse sectors such as pharmaceutical and biotechnology companies, diagnostic laboratories, academic and research institutions, and government agencies.
The company's expertise spans translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, and informatics.
Company Size and Financials
With a global workforce exceeding 11,000 employees, Revvity serves clients across more than 190 countries. The company's revenue for 2024 was approximately $2.755 billion.
Locations
Revvity operates several offices in the United States, including key locations in:
- Providence, Rhode Island
- Raleigh, North Carolina
- Boston, Massachusetts
Strategic Acquisitions
In 2021, the company acquired BioLegend, a global developer and manufacturer of antibodies and reagents used in biomedical research, for $5.25 billion. This acquisition strengthened Revvity's position in life sciences, particularly in neuroscience, cell immunophenotyping, and cancer research.
Commitment to Innovation
Revvity's commitment to innovation and excellence is evident in its diverse product portfolio and global presence. The company remains a significant player in the health sciences and diagnostics industry.